2-Hydroxy-4-methoxybenzophenone | CAS:131-57-7

We serve 2-Hydroxy-4-methoxybenzophenone CAS:131-57-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2-Hydroxy-4-methoxybenzophenone

Product Name: 2-Hydroxy-4-methoxybenzophenone
Other Name: Benzophenone-3 (Bp-3)
CAS No: 131-57-7
MF: C14H12O3
MW: 228.24300
Density: 1.3 g/cm3
Boiling point: 150-160 °C5 mm Hg(lit.)
Melting point: 62-64 °C(lit.)
Flash point: 216°C
Refractive index: 1.595
UN Number: Not dangerous goods.
UN Proper Shipping Name: Not dangerous goods.
Transport hazard class: Not dangerous goods.
Packing group: Not dangerous goods.
 
Specification
Appearance: Light yellow crystalline powder
Assay: ≥99%
Ash: ≤0.10%
Loss on drying: ≤0.50%
 
Application
The UV absorber UV-9 can effectively absorb 270-340 nm UV light and absorb almost no visible light, so it is especially suitable for light-colored transparent products.
This product has good light and heat stability and does not decompose at 200 °C. 
It can be used in paints and various plastic products. It is especially effective for polyvinyl chloride, polystyrene, polyurethane, acrylic resin and light-colored transparent furniture. 
It is also a good cosmetic additive. The dosage is 0.1-0.5%.
 
Package: Packed in cardboard drum lined with plastic bag, net weight 25kg/drum, can also be designed according to customer requirements.
Storage: UV absorber UV-9 is non-toxic, non-flammable, non-explosive, non-corrosive, and has good storage stability.



Contact us for information like 2-Hydroxy-4-methoxybenzophenone chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Benzophenone-3 (Bp-3) physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzophenone-3 (Bp-3) Use and application,2-Hydroxy-4-methoxybenzophenone technical grade,usp/ep/jp grade.


Related News: ICIG has agreed to offer employment to the unit’s approximately 120 employees upon closing, and plans to maintain operations at its primary location, a manufacturing facility in Liestal, Switzerland.3,4-Difluoro-2-methylbenzonitrile manufacturer The intravenous form of rigosertib has been studied in Phase 1, 2, and 3 clinical trials involving more than 1000 patients, and is currently being evaluated in a randomized Phase 3 international INSPIRE trial for patients with HR-MDS after failure of HMA therapy.Spiro[9H-fluorene-9,9'-[9H]xanthene], 2-bromo- supplier We are pleased that he is doing well,” said BPHC Executive Director Rita Nieves. “Right now, we are not asking Boston residents to do anything differently.1-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one vendor Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.Airlines operating in the United States will be required to ask all passengers booked on flights from outside the US if they’ve been to mainland China in last 14 days.